We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTES icon
2651
NetEase
NTES
$83B
$551K ﹤0.01%
+7,300
New +$642K
CYPH
2652
Cypherpunk Technologies Inc
CYPH
$64M
$547K ﹤0.01%
62,238
-18,906
-23% -$230K
VEON icon
2653
VEON
VEON
$3.5B
$547K ﹤0.01%
67,986
PRO
2654
DELISTED
PROS Holdings
PRO
$546K ﹤0.01%
+22,096
New +$536K
FISV
2655
PUT
Fiserv Inc
FISV
$29.7B
$543K ﹤0.01%
+5,800
New +$591K
ORIAW
2656
CALL
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$543K ﹤0.01%
54,995
ADV icon
2657
Advantage Solutions
ADV
$575M
$541K ﹤0.01%
+10,160
New +$937K
PTEN icon
2658
Patterson-UTI
PTEN
$3.54B
$541K ﹤0.01%
+46,300
New +$662K
YI
2659
111 Inc
YI
$31.3M
$539K ﹤0.01%
20,180
-697
-3% -$18.8K
ACCD
2660
DELISTED
Accolade Inc
ACCD
$539K ﹤0.01%
47,184
+27,409
+139% +$299K
JKHY icon
2661
Jack Henry & Associates
JKHY
$11.4B
$538K ﹤0.01%
+2,953
New +$579K
PMVP icon
2662
PMV Pharmaceuticals
PMVP
$57.1M
$538K ﹤0.01%
+45,207
New +$653K
ROCL
2663
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$538K ﹤0.01%
+53,910
New +$534K
FXB icon
2664
PUT
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.1M
$535K ﹤0.01%
5,000
+3,100
+163% +$350K
ADTN icon
2665
Adtran
ADTN
$675M
$533K ﹤0.01%
26,773
+14,546
+119% +$317K
TER icon
2666
Teradyne
TER
$50B
$533K ﹤0.01%
+7,100
New +$647K
RDW.WS
2667
CALL
DELISTED
Redwire Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
RDW.WS
$533K ﹤0.01%
223,754
-12,417
-5% -$5.76K
DOMO icon
2668
Domo
DOMO
$171M
$529K ﹤0.01%
29,421
+14,488
+97% +$380K
GNRC icon
2669
Generac Holdings
GNRC
$11.5B
$529K ﹤0.01%
2,973
-6,733
-69% -$1.54M
CVLY
2670
DELISTED
Codorus Valley Bancorp Inc
CVLY
$529K ﹤0.01%
+28,092
New +$589K
EWA icon
2671
iShares MSCI Australia ETF
EWA
$1.38B
$528K ﹤0.01%
+26,922
New +$585K
TUSK icon
2672
Mammoth Energy Services
TUSK
$122M
$528K ﹤0.01%
154,899
-54,333
-26% -$189K
ATYR
2673
aTyr Pharma
ATYR
$47.4M
$527K ﹤0.01%
175,910
+16,503
+10% +$55.3K
ARBEW icon
2674
CALL
Arbe Robotics Warrant
ARBEW
$336K
$525K ﹤0.01%
87,307
-26,976
-24% -$18.2K
GAIN icon
2675
Gladstone Investment Corp
GAIN
$642M
$525K ﹤0.01%
+43,344
New +$623K

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.